ALS LIMITED — Major Shareholding Notification 2022

Jul 3, 2022

Form 604

Corporations Act 2001 Section 671B

Notice of change of interests of substantial holder

To Company Name/Scheme HRL Holdings Ltd ( HRL ) ACN/ARSN ACN 120 896 371

1. Details of substantial holder (1)

Form 604 Corporations Act 2001 Section 671B Notice of change of interests of substantial holder	Form 604 Corporations Act 2001 Section 671B Notice of change of interests of substantial holder	Form 604 Corporations Act 2001 Section 671B Notice of change of interests of substantial holder
ToCompany Name/Scheme HRL Holdings Ltd(HRL) ACN/ARSN ACN 120 896 371 1. Details of substantial holder (1)
Name Australian Laboratory Services Pty. Ltd. (ACN 009 936 029) and ALS Limited (ACN 009 657 489) ACN/ARSN (if applicable) As above There was a change in the interests of the substantial holder on 01 / 07 / 2022 The previous notice was given to the company on 01 / 07 / 2022 The previous notice was dated 01 / 07 / 2022 2. Previous and present voting power The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an relevant interest(3)in when last required,and when now required,togive a substantial holdingnotice to the companyor scheme,are as follows: Class of securities (4) Previous notice Present notice Person’s votes Voting power(5) Person’s votes Voting power Fully paid ordinary shares in HRL 98,876,260 19.99% 331,602,865 67.07% 3. Changes in relevant interests Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows: Date of change Person whose relevant interest changed Nature of change (6) Consideration given in relation to change (7) Class and number of securities affected Person’s votes affected 01 / 07 / 2022 Australian Laboratory Services Pty. Ltd. (ACN 009 936 029) Acquisition of fully paid ordinary shares in HRL by Australian Laboratory Services Pty. Ltd. (ACN 009 936 029) by on- market purchase $37,236,256.80 (being $0.16 per fully paid ordinary share in HRL) 232,726,605 fully paid ordinary shares in HRL 232,726,605 01 / 07 / 2022 ALS Limited (ACN 009 657 489) Acquisition of fully paid ordinary shares in HRL by Australian Laboratory Services Pty. Ltd. (ACN 009 936 029) by on- market purchase $37,236,256.80 (being $0.16 per fully paid ordinary share in HRL) 232,726,605 fully paid ordinary shares in HRL 232,726,605	Australian Laboratory Services Pty. Ltd. (ACN 009 936 029) and ALS Limited (ACN 009 657 489)
	As above

4. Present relevant interests

Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:

Holder of relevant interest	Registered holder of securities	Person entitled to be registered as holder (8)	Nature of relevant interest (6)	Class and number of securities	Person’s votes
Australian Laboratory Services Pty. Ltd. (ACN 009 936 029)	Australian Laboratory Services Pty. Ltd. (ACN 009 936 029)	Australian Laboratory Services Pty. Ltd. (ACN 009 936 029)	Registered holder of securities - Section 608(1)(a) of the_Corporations_ Act 2001(Cth)	331,602,865 fully paid ordinary shares in HRL	331,602,865
ALS Limited (ACN 009 657 489)	Australian Laboratory Services Pty. Ltd. (ACN 009 936 029)	Australian Laboratory Services Pty. Ltd. (ACN 009 936 029)	Relevant interest in securities held by a body corporate in which the person's voting power is above 20% (ALS Limited (ACN 009 657 489) has voting power above 20% in Australian Laboratory Services Pty. Ltd. (ACN 009 936 029)) - Section 608(3)(a) of the Corporations Act 2001(Cth)	331,602,865 fully paid ordinary shares in HRL	331,602,865

5. Changes in association

The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the relation to voting interests in the company or scheme are as follows:

Name and ACN/ARSN (if applicable)	Nature of association
N/A - no changes from the previous notice	N/A - no changes from the previous notice
N/A - no changes from the previous notice	N/A - no changes from the previous notice

6. Addresses

The addresses of persons named in this form are as follows:

Name	Address
Australian Laboratory Services Pty. Ltd. (ACN 009 936 029)	Level 2, 299 Coronation Drive, Milton, Queensland, 4064
ALS Limited (ACN 009 657 489)	Level 2, 299 Coronation Drive, Milton, Queensland, 4064

Signature

	Michael Paul Pearson	capacity	Company secretary of
			Australian Laboratory
			Services Pty. Ltd. (ACN 009
			936 029) and ALS Limited
			(ACN 009 657 489)
		date	04 / 07 / 2022

print name Michael Paul Pearson

sign here

DIRECTIONS

• (1) If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.

• (2) See the definition of "associate" in section 9 of the Corporations Act 2001.

• (3) See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.

• (4) The voting shares of a company constitute one class unless divided into separate classes.

• (5) The person’s votes divided by the total votes in the body corporate or scheme multiplied by 100.

• (6) Include details of:

(any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any adocument setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or )arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and

(any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to bwhich the relevant interest relates (indicating clearly the particular securities to which the qualification applies). )

See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.

• (7) Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included on any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.

• (8) If the substantial holder is unable to determine the identity of the person (eg. if the relevant interest arises because of an option) write “unknown’”.

• (9) Give details, if appropriate, of the present association and any change in that association since the last substantial holding notice.